Euroapi Company Header Euroapi Company Header

X

CAS 826-55-1 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 826-55-1
Also known as: 826-55-1, 2-methyl-2-phenylpropanoic acid, 2-methyl-2-phenylpropionic acid, Alpha,alpha-dimethylphenylacetic acid, Dimethylphenylacetic acid, Hydratropic acid, .alpha.-methyl-
Molecular Formula
C10H12O2
Molecular Weight
164.20  g/mol
InChI Key
YYEROYLAYAVZNW-UHFFFAOYSA-N
FDA UNII
DR8HUH2GYK

1 2D Structure

CAS 826-55-1

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-methyl-2-phenylpropanoic acid
2.1.2 InChI
InChI=1S/C10H12O2/c1-10(2,9(11)12)8-6-4-3-5-7-8/h3-7H,1-2H3,(H,11,12)
2.1.3 InChI Key
YYEROYLAYAVZNW-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)(C1=CC=CC=C1)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
DR8HUH2GYK
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 826-55-1

2. 2-methyl-2-phenylpropanoic Acid

3. 2-methyl-2-phenylpropionic Acid

4. Alpha,alpha-dimethylphenylacetic Acid

5. Dimethylphenylacetic Acid

6. Hydratropic Acid, .alpha.-methyl-

7. Dr8huh2gyk

8. Mfcd00014332

9. 2-phenyl-2-methylpropionic Acid

10. 2-methyl-2-phenyl-propionic Acid

11. Nsc-28952

12. Nsc-29095

13. .alpha.,.alpha.-dimethylphenylacetic Acid

14. .alpha.,.alpha.-dimethylbenzeneacetic Acid

15. Benzeneacetic Acid,.alpha.-dimethyl-

16. Propionic Acid, 2-methyl-2-phenyl-

17. .alpha.-toluic Acid,.alpha.-dimethyl-

18. Th 4161

19. Unii-dr8huh2gyk

20. 2-methyl-2-phenylpropionicacid

21. Phenylisobuttersaure

22. Einecs 212-556-3

23. Phenylisobutyric Acid

24. Benzeneacetic Acid, .alpha.,.alpha.-dimethyl-

25. Ec 212-556-3

26. Schembl6571

27. A,a-dimethylbenzeneacetic Acid

28. Yyeroylayavznw-uhfffaoysa-

29. Dtxsid90231907

30. 2-methyl-2-phenyl Propanoic Acid

31. 2-methyl-2-phenyl- Propionic Acid

32. 2,2-dimethyl-2-phenyl-acetic Acid

33. Albb-023531

34. Nsc28952

35. Nsc29095

36. Zinc1651856

37. Ac-370

38. Nsc 28952

39. Nsc 29095

40. Alpha, Alpha-dimethylphenylacetic Acid

41. Alpha,alpha-dimethylbenzeneacetic Acid

42. Akos000121417

43. Cs-w004146

44. Alpha , Alpha -dimethylphenylacetic Acid

45. 2,2-dimethyl-2-phenylacetic Acid

46. As-10791

47. Benzeneacetic Acid, Alpha,alpha-dimethyl-

48. Sy001281

49. Db-056644

50. 2-methyl-2-phenylpropanoic Acid, Aldrichcpr

51. Am20041211

52. Ft-0622096

53. P1409

54. L10018

55. Ae-562/43450611

56. W-104168

57. Q27276560

58. Z1270387215

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 164.20 g/mol
Molecular Formula C10H12O2
XLogP31.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass164.083729621 g/mol
Monoisotopic Mass164.083729621 g/mol
Topological Polar Surface Area37.3 Ų
Heavy Atom Count12
Formal Charge0
Complexity167
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
URL Supplier Web Content
110963-63-8
Bilastine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
17178-11-9
Bilastine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
1181267-33-3
Bilastine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
1841081-72-8
Bilastine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
38385-95-4
Bilastine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
32454-35-6
Bilastine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
202189-76-2
Bilastine
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY